These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19644135)

  • 1. Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.
    Cazzola M
    Haematologica; 2009 Aug; 94(8):1041-3. PubMed ID: 19644135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research in morphology and flow cytometry is at the heart of hematology.
    Béné MC; Zini G;
    Haematologica; 2017 Mar; 102(3):421-422. PubMed ID: 28250005
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunophenotyping of acute leukemias and myelodysplastic syndromes.
    Orfao A; Ortuño F; de Santiago M; Lopez A; San Miguel J
    Cytometry A; 2004 Mar; 58(1):62-71. PubMed ID: 14994223
    [No Abstract]   [Full Text] [Related]  

  • 4. Issue Highlights - May 2019.
    Orfao A
    Cytometry B Clin Cytom; 2019 May; 96(3):177-180. PubMed ID: 31091004
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study.
    Ogata K; Della Porta MG; Malcovati L; Picone C; Yokose N; Matsuda A; Yamashita T; Tamura H; Tsukada J; Dan K
    Haematologica; 2009 Aug; 94(8):1066-74. PubMed ID: 19546439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome.
    Elghetany MT
    Blood; 2002 Jan; 99(1):391-2. PubMed ID: 11783436
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of bone marrow cells immunophenotypic study by flow cytometry in diagnosing myelodysplastic syndrome].
    Czyz A; Dworacki G; Komarnicki M
    Postepy Hig Med Dosw (Online); 2008 Jul; 62():354-63. PubMed ID: 18688206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of flow cytometric immunophenotyping in diagnosis of myelodysplastic syndromes--review].
    Zhang Y; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1477-81. PubMed ID: 19099668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.
    van de Loosdrecht AA; Alhan C; Béné MC; Della Porta MG; Dräger AM; Feuillard J; Font P; Germing U; Haase D; Homburg CH; Ireland R; Jansen JH; Kern W; Malcovati L; Te Marvelde JG; Mufti GJ; Ogata K; Orfao A; Ossenkoppele GJ; Porwit A; Preijers FW; Richards SJ; Schuurhuis GJ; Subirá D; Valent P; van der Velden VH; Vyas P; Westra AH; de Witte TM; Wells DA; Loken MR; Westers TM
    Haematologica; 2009 Aug; 94(8):1124-34. PubMed ID: 19546437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.
    Cremers EMP; Westers TM; Alhan C; Cali C; Wondergem MJ; Poddighe PJ; Ossenkoppele GJ; van de Loosdrecht AA
    Eur J Cancer; 2016 Feb; 54():49-56. PubMed ID: 26720403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of flow cytometric immunophenotyping in myelodysplastic syndromes.
    Pagnucco G; Giambanco C; Gervasi F
    Ann N Y Acad Sci; 2006 Nov; 1089():383-94. PubMed ID: 17261782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry for diagnosis and assessment of prognosis in patients with myelodysplastic syndromes.
    Benesch M; Deeg HJ; Wells D; Loken M
    Hematology; 2004 Jun; 9(3):171-7. PubMed ID: 15204098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.
    Alhan C; Westers TM; Cremers EM; Cali C; Ossenkoppele GJ; van de Loosdrecht AA
    Cytometry B Clin Cytom; 2016 Jul; 90(4):358-67. PubMed ID: 26517178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes.
    Goardon N; Nikolousis E; Sternberg A; Chu WK; Craddock C; Richardson P; Benson R; Drayson M; Standen G; Vyas P; Freeman S
    Haematologica; 2009 Aug; 94(8):1160-3. PubMed ID: 19644143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes.
    Huang J; Lai P; Zhou M; Weng J; Lu Z; Du X
    Clin Lab; 2012; 58(11-12):1241-51. PubMed ID: 23289195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotyping of myelodysplasia.
    Béné MC
    Haematologica; 2003 Apr; 88(4):363. PubMed ID: 12681961
    [No Abstract]   [Full Text] [Related]  

  • 17. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.
    Della Porta MG; Lanza F; Del Vecchio L;
    Cytometry B Clin Cytom; 2011; 80(4):201-11. PubMed ID: 21674774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
    Ogata K; Sei K; Saft L; Kawahara N; Porta MGD; Chapuis N; Yamamoto Y
    Leuk Res; 2018 Aug; 71():75-81. PubMed ID: 30025279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients.
    Kern W; Bacher U; Haferlach C; Alpermann T; Schnittger S; Haferlach T
    Cytometry B Clin Cytom; 2015; 88(3):154-64. PubMed ID: 25581461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research advances in value of flow cytometric immunophenotyping in diagnosis and prognostic evaluation of myelodysplastic syndrome].
    Lu D; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):785-90. PubMed ID: 23815941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.